Westlake Chemical Partners LP Announces Third Quarter 2026 Results

Westlake Chemical Partners LP (WLKP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 WESTLAKE CHEMICAL PARTNERS LP Contact—(713) 585-2900 Investors—Jeff Holy Media—L. Benjamin Ederington Westlake Chemical Partners LP Announces Third Quarter 2026 Results • Declared quarterly distribution of $0.4714 per unit; 49 th consecutive quarterly distribution HO

Original reporting
Published Nov 4, 2026, 12:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 12:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$WLKP
Neutral
high confidence
Mentioned
$WLKP
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$WLKPNeutralMed
01

Why it matters

The disclosed higher net income and distribution may support the unit price, but market reaction will depend on forward guidance and commodity price trends.

02

Market read

Earnings release provides fresh data for income‑focused investors and may influence related MLPs.

03

What to watch

Potential downside from higher feedstock costs or geopolitical tensions affecting ethylene margins.

Relevance 7/10Novelty 7/10Timing: after‑hours release
AlphAI · Earnings readWLKP · third quarter of 2026 · ended September 30, 2026

Westlake Chemical Partners LP Announces Third Quarter 2026 Results

✓Solid quarter

Third-quarter net income attributable to Westlake Partners, EBITDA and MLP distributable cash flow increased both year over year and sequentially, while the Partnership declared its 49th consecutive quarterly distribution and reported trailing twelve-month coverage of 1.09x.

Revenue
$314M
Net sales—Westlake Corporation, three months ended September 30, 2026
$262M

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Total net sales, three months ended September 30GAAP$314.5M––
Net sales—Westlake Corporation, three months ended September 30GAAP$261.9M––
Net co-products, ethylene and other sales—third parties, three months ended September 30GAAP52,524––
Cost of sales, three months ended September 30GAAP210,563––
Gross profit, three months ended September 30GAAP103,896––
Selling, general and administrative expenses, three months ended September 30GAAP8,336––
Income from operations, three months ended September 30GAAP95,560––
Interest expense—Westlake, three months ended September 30GAAP(5,110)––
Other income, net, three months ended September 30GAAP565––
Income before income taxes, three months ended September 30GAAP91,015––
Provision for income taxes, three months ended September 30GAAP158––
Net income, three months ended September 30GAAP90,857––
Net income attributable to noncontrolling interest in OpCo, three months ended September 30GAAP74,638––
Net income attributable to Westlake Partners, three months ended September 30GAAP$16.22Mincreased by $2.0 million–
Net income per limited partner unit attributable to Westlake Partners, common units, basic and diluted, three months ended September 30GAAP$ 0.46––
Distributions declared per unit, three months ended September 30other$ 0.4714––
MLP distributable cash flow, three months ended September 30non-GAAP$17.98Mincreased by $0.4 millionincreased by $3.1 million
Total distributions declared, three months ended September 30other$16.62M––
EBITDA, three months ended September 30non-GAAP$128.3M––
Cash flows from operating activities, three months ended September 30GAAP$122.2Mdecreased by $7.6 millionan increase of $17.0 million
Total net sales, nine months ended September 30GAAP917,234––
Net sales—Westlake Corporation, nine months ended September 30GAAP$763.1M––
Net co-products, ethylene and other sales—third parties, nine months ended September 30GAAP154,178––
Cost of sales, nine months ended September 30GAAP624,774––
Gross profit, nine months ended September 30GAAP292,460––
Selling, general and administrative expenses, nine months ended September 30GAAP23,020––
Income from operations, nine months ended September 30GAAP269,440––
Net income, nine months ended September 30GAAP254,874––
Net income attributable to Westlake Partners, nine months ended September 30GAAP$44.63M––
Net income per limited partner unit attributable to Westlake Partners, common units, basic and diluted, nine months ended September 30GAAP$ 1.27––
MLP distributable cash flow, nine months ended September 30non-GAAP$53.5M––
EBITDA, nine months ended September 30non-GAAP$372.2M––

Segments

SegmentRevenueq/qy/y
Net sales—Westlake Corporation, three months ended September 30, 2026No segment-specific driver was provided.$261.9M––
Net co-products, ethylene and other sales—third parties, three months ended September 30, 2026No segment-specific driver was provided.52.52M––

Amounts quoted below without a unit are in thousands, as in the filing’s tables. Per-share figures are as printed.

Capital returns

  • Quarterly distribution for the third quarter of 2026 of $0.4714 per common unit, payable on December 1, 2026 to unitholders of record as of November 13, 2026.
  • The distribution represents the 49th consecutive quarterly distribution to unitholders.
  • Limited partner units—publicly and privately held distributions declared were $ 9,961 for the three months ended September 30, 2026.
  • Limited partner units—Westlake distributions declared were 6,657 for the three months ended September 30, 2026.
  • Total distributions declared were $ 16,618 for the three months ended September 30, 2026.
  • Trailing twelve-month coverage ratio was 1.09x, compared with 1.04x at the end of the second quarter.
  • Cumulative coverage ratio since the July 2014 IPO is approximately 1.05x.

What drove it

  • Third-quarter net income attributable to the Partnership increased from the second quarter due to higher production and sales volume.
  • Third-quarter MLP distributable cash flow increased from the prior-year quarter primarily due to lower maintenance capital expenditures and higher sales volume.
  • Third-quarter operating cash flow increased from the prior-year quarter primarily due to more favorable changes in working capital.
  • The Ethylene Sales Agreement provides that 95% of OpCo's ethylene production is sold to Westlake for a cash margin of $0.10 per pound, net of operating costs, maintenance capital expenditures and reserves for future turnaround expenditures.

Concerns

  • Third-quarter cash flows from operating activities decreased sequentially due to less favorable working capital changes.
  • Net sales—Westlake Corporation were $ 261,935 in the third quarter of 2026, compared with $ 276,539 in the third quarter of 2025.
  • The Partnership identifies risks relating to operating disruptions, production volume, ethylene pricing, feedstock and energy costs, customer delivery, supply and demand, and political tension and conflict in the Middle East and elsewhere.

What to watch

  • Production and sales volume, which management cited as the driver of sequential increases in net income attributable to the Partnership and MLP distributable cash flow.
  • Working-capital changes, which drove the sequential decline in operating cash flow.
  • Maintenance capital expenditures and turnaround reserves, which affect MLP distributable cash flow.
  • The stability and cash-flow benefits of the Ethylene Sales Agreement with Westlake.
  • Trailing twelve-month distribution coverage following the increase to 1.09x.

Balance sheet and cash flow

  • Cash and cash equivalents were $ 47,649 at September 30, 2026, compared with $ 44,269 at December 31, 2025.
  • Receivable under the Investment Management Agreement—Westlake was 65,715 at September 30, 2026, compared with 23,378 at December 31, 2025.
  • Total assets were $ 1,225,204 at September 30, 2026, compared with $ 1,256,533 at December 31, 2025.
  • Long-term debt payable to Westlake was 399,674 at September 30, 2026 and 399,674 at December 31, 2025.
  • Total liabilities were 454,919 at September 30, 2026, compared with 454,181 at December 31, 2025.
  • Total equity was 770,285 at September 30, 2026, compared with 802,352 at December 31, 2025.
  • Net cash provided by operating activities was 362,205 for the nine months ended September 30, 2026, compared with 160,090 for the nine months ended September 30, 2025.
  • Additions to property, plant and equipment were (29,724) for the nine months ended September 30, 2026, compared with (69,988) for the nine months ended September 30, 2025.
  • Investments with Westlake under the Investment Management Agreement were (42,000) for the nine months ended September 30, 2026.
  • Net cash used for financing activities was (287,101) for the nine months ended September 30, 2026, compared with (230,482) for the nine months ended September 30, 2025.
  • Cash and cash equivalents at end of period were $ 47,649 for the nine months ended September 30, 2026, compared with $ 37,936 for the nine months ended September 30, 2025.

Analysis

Westlake Chemical Partners reported improved third-quarter profitability and distributable cash flow. Net income attributable to Westlake Partners was $ 16,219, compared with $ 14,653 in the prior-year quarter, while EBITDA was $ 128,329 versus $ 126,075. MLP distributable cash flow was $ 17,978, compared with $ 14,886. Management attributed the year-over-year increase in MLP distributable cash flow primarily to lower maintenance capital expenditures and higher sales volume.

The sequential trend was also positive in earnings measures. The Partnership said net income attributable to the Partnership increased by $2.0 million from the second quarter due to higher production and sales volume, and MLP distributable cash flow increased by $0.4 million for the same reason. EBITDA was $ 128,329 in the third quarter, compared with $ 122,687 in the second quarter. Operating cash flow moved in the other direction sequentially, declining by $7.6 million to $122.2 million because of less favorable working-capital changes.

Revenue mix showed lower sales to Westlake alongside higher third-party sales. Net sales—Westlake Corporation were $ 261,935 in the third quarter, compared with $ 276,539 a year earlier, while net co-products, ethylene and other sales—third parties were 52,524 compared with 32,359. Total net sales were $ 314,459 compared with $ 308,898, and gross profit was 103,896 compared with 99,423. Income from operations was 95,560 compared with 91,979.

Capital returns remained unchanged at $0.4714 per common unit, marking the 49th consecutive quarterly distribution. The trailing twelve-month coverage ratio was 1.09x, above 1.04x at the end of the second quarter. The Partnership's stated cash-flow stability remains linked to its Ethylene Sales Agreement with Westlake, under which 95% of OpCo's ethylene production is sold to Westlake for a cash margin of $0.10 per pound, net of specified costs and reserves. Management provided no quantitative forward guidance, but stated that it expects earnings and cash flows to continue to benefit from the agreement's stability.

Management, verbatim

We were pleased with the Partnership's performance in the third quarter of 2026, with net income, EBITDA and MLP distributable cash flow all increasing from the second quarter.

Jean-Marc Gilson, President and Chief Executive Officer

Looking forward, we expect our earnings and cash flows to continue to benefit from the stability provided by our ethylene sales agreement with Westlake.

Jean-Marc Gilson, President and Chief Executive Officer

Not in the filing

stated, not guessed
  • Quantitative forward revenue guidance
  • Quantitative gross-margin guidance
  • Quantitative operating-expense guidance
  • Quantitative tax-rate guidance
  • Prior guidance or prior outlook for comparison
  • Reported gross margin percentage
  • Free cash flow
  • Share repurchases
  • Quarterly balance sheet comparison with the immediately preceding quarter

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was checked against the filing text, and a metric whose value, prior period and change do not add up is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Background

The filing is a standard Form 8‑K earnings release for Westlake Chemical Partners, an MLP listed on NYSE.

Company-level read

Ticker impact

$WLKPNeutralHigh confidence
Context

Westlake Chemical Partners reported Q3 2026 net income of $16.2M and a quarterly distribution of $0.4714 per unit, higher than the prior year.

Expected impact

potential modest upside as investors price in higher earnings and distribution

Evidence & confidence

Quarterly results exceed prior-year figures and show improved cash flow, which may attract income‑focused investors.

Market effects

Positive earnings may lift other MLPs and midstream chemical distributors.

Limited to U.S. energy‑related investors.

Minimal global impact beyond the U.S. MLP sector.

Counterpoint

If the earnings beat is already priced in, the stock could face profit‑taking pressure.

Key entities

  • Westlake Chemical Partners LP

    MLP that reports quarterly earnings and distributions.

  • Westlake Corporation

    Counterparty in the ethylene sales agreement providing cash flow stability.

Every WLKP earnings report

This story covers one filing. The ticker page keeps them all: each quarter's reported metrics with year-over-year and sequential comparisons, segments, guidance, and how the numbers landed against the company's own prior outlook.

Related articles

$WLKMed

Westlake Chemical Partners LP Q3 2026 Earnings Call Summary

Westlake Chemical Partners LP reported Q3 2026 net income growth due to higher production and sales volumes. Distributable cash flow rose to $18 million, with a trailing 12-month coverage ratio of 1.09x. Management expects modest benefits from rising ethylene prices in Q4 2026 and plans to begin renegotiating the Ethylene Sales Agreement next year. The company maintains a conservative leverage ratio of 1x and has sustained distributions for 49 consecutive quarters.

$WLKPMed

Westlake Chemical Partners Q2 Earnings Call Highlights

Westlake Chemical Partners (NYSE:WLKP) reported Q2 net income of $14 million, or $0.40 per unit, and distributable cash flow of $18 million, or $0.50 per unit. The quarterly distribution was $0.4714 per unit, with a 1.04x trailing coverage ratio. Consolidated net sales were $297 million. The partnership extended revolvers through 2031 and leadership shifted to John Bochert as CFO.

$WLKPMed

Westlake Chemical Partners LP Announces Second Quarter 2026 Results

Westlake Chemical Partners LP (WLKP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 WESTLAKE CHEMICAL PARTNERS LP Contact—(713) 585-2900 Investors—Jonathan Baksht Media—L. Benjamin Ederington Westlake Chemical Partners LP Announces Second Quarter 2026 Results • Declared quarterly distribution of $0.4714 per unit; 48 th consecutive quarterly distribu

$WLKPMedAI 8/10

Westlake Chemical Partners LP Announces Second Quarter 2026 Results

Westlake Chemical Partners LP (NYSE: WLKP) reported Q2 2026 net income attributable to the partnership of $14.2 million, or $0.40 per limited partner unit, versus $14.6 million in Q2 2025. Operating cash flow was $129.8 million. It declared a $0.4714 per unit distribution, 48th consecutive quarter, with trailing twelve-month coverage of 1.04x. Credit facilities were amended to extend maturities to July 2031.